EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr |
What is the latest Total Non-Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹3,566 Cr |
| Mar2024 | ₹3,449 Cr |
| Mar2023 | ₹2,737 Cr |
| Mar2022 | ₹2,523 Cr |
| Mar2021 | ₹2,942 Cr |
How is Total Non-Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,566 Cr | 3.37 | |
| Mar2024 | ₹3,449 Cr | 26.01 | |
| Mar2023 | ₹2,737 Cr | 8.49 | |
| Mar2022 | ₹2,523 Cr | -14.22 | |
| Mar2021 | ₹2,942 Cr | - | |
Compare Total Non-Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,432.6 Cr | -6.1% | 7.4% | 48% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -6.1% |
7.4% |
48% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses